Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to test the hypothesis that at least 1 LY2439821 treatment group is superior to placebo in the proportion of adult patients with moderate-to-severe chronic plaque psoriasis who achieve a 75% improvement from baseline to Week 12 in the Psoriasis Area and Severity Index (PASI 75) and to estimate the percentage PASI improvement by treatment using regression techniques.
Critère d'inclusion
- Patients With Moderate-To-Severe Psoriasis